Skip to main content
BrainCited

Descrizione

Differentiation pathway of Th17 cells from naive CD4+ T cells, highlighting the cytokine milieu (IL-6, TGF-beta, IL-23) required for lineage commitment. The role of RORgamma-t transcription factor is depicted.

Figure 1

Diagram

Source Paper

The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.

Evidence-based complementary and alternative medicine : eCAM (2011)

PMID: 19622601

DOI: 10.1093/ecam/nep063

Cite This Figure

![Figure 1: Differentiation pathway of Th17 cells from naive CD4+ T cells, highlighting the cytokine milieu (IL-6, TGF-beta, IL-23) required for lineage commitment. The role of RORgamma-t transcription factor is depicted.]()

> Source: Aristo Vojdani et al. "The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.." *Evidence-based complementary and alternative medicine : eCAM*, 2011. PMID: [19622601](https://pubmed.ncbi.nlm.nih.gov/19622601/)
<figure>
  <img src="" alt="Differentiation pathway of Th17 cells from naive CD4+ T cells, highlighting the cytokine milieu (IL-6, TGF-beta, IL-23) required for lineage commitment. The role of RORgamma-t transcription factor is depicted." />
  <figcaption>Figure 1. Differentiation pathway of Th17 cells from naive CD4+ T cells, highlighting the cytokine milieu (IL-6, TGF-beta, IL-23) required for lineage commitment. The role of RORgamma-t transcription factor is depicted.<br>  Source: Aristo Vojdani et al. "The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.." <em>Evidence-based complementary and alternative medicine : eCAM</em>, 2011. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/19622601/">19622601</a></figcaption>
</figure>